MMR (Measles, Mumps, and Rubella) Vaccines
Measles, Mumps, and Rubella are three highly contagious viral diseases that can lead to serious complications such as pneumonia, encephalitis, infertility, or congenital rubella syndrome in pregnant women.
The MMR vaccine provides safe, long-term protection against all three diseases in a single injection and remains one of the most effective and essential immunizations recommended worldwide.
Affinity Vaccines offers MMR vaccines approved by the Philippine FDA and World Health Organization (WHO) — ideal for adult catch-up immunization, dependent programs, and pre-employment or travel vaccination requirements.
A. Priorix® (GlaxoSmithKline – GSK)
Formulation:
Live attenuated measles (Schwarz strain), mumps (RIT 4385 strain derived from Jeryl Lynn), and rubella (Wistar RA 27/3 strain) viruses, each propagated in chick embryo or human diploid (MRC-5) cell cultures. Lyophilized for reconstitution.
Packaging:
Single-dose vial (lyophilized powder) with pre-filled syringe of sterile water diluent, yielding 0.5 mL after reconstitution.
Dosage and Administration:
- Children (≥ 12 months): One 0.5 mL subcutaneous dose; a second dose recommended at least 4 weeks later.
- Adults: Two doses, 0.5 mL each, at least 4 weeks apart for full protection.
Indications:
Active immunization against measles, mumps, and rubella in individuals 12 months of age and older.
Contraindications:
- Hypersensitivity to neomycin or any vaccine component.
- Immunodeficiency or immunosuppressive therapy.
- Pregnancy (avoid conception for one month post-vaccination).
- Defer during febrile or acute illness.
Storage / Cold-Chain Requirement:
- Store between +2°C and +8°C.
- Do not freeze.
- Protect from light; use immediately after reconstitution.
Manufacturer:
GlaxoSmithKline Biologicals S.A., Belgium
B. MMR-II® (Merck Sharp & Dohme – MSD)
Formulation:
Live attenuated measles (Enders Edmonston strain), mumps (Jeryl Lynn [B] strain), and rubella (Wistar RA 27/3 strain) viruses, lyophilized and supplied with diluent.
Packaging:
Single-dose vial (lyophilized vaccine) with pre-filled syringe of diluent, 0.5 mL after reconstitution.
Dosage and Administration:
- Children (≥ 12 months): One 0.5 mL SC dose; second dose after 4–6 weeks.
- Adults: Two doses, 0.5 mL each, separated by at least 4 weeks.
Indications:
Active immunization against measles, mumps, and rubella in persons 12 months and older.
Contraindications:
- Hypersensitivity to neomycin or any component, including gelatin.
- Immunocompromised individuals.
- Pregnancy (avoid for one month post-vaccination).
- Delay vaccination if febrile or moderately ill.
Storage / Cold-Chain Requirement:
- Maintain +2°C to +8°C.
- Do not freeze reconstituted vaccine.
- Protect from light and administer immediately after mixing.
Manufacturer:
Merck Sharp & Dohme Corp., USA
Corporate Vaccination Recommendations
Target Group | Recommended Vaccine | Notes |
Adults with no record of MMR vaccination | Priorix® or MMR-II® (2 doses) | Catch-up protection against all three viruses. |
College students, healthcare, hospitality, or overseas employees | MMR-II® / Priorix® (2 doses) | Often required for school, visa, or employment. |
Female employees of child-bearing age | Priorix® (pre-pregnancy) | Prevents congenital rubella; contraindicated during pregnancy. |
Pediatric dependents (≥ 12 months)** | Priorix® or MMR-II® | Routine childhood immunization; second dose ensures lifelong immunity. |
Affinity Vaccines Recommendation:
For adult or workforce immunization, a two-dose series of either Priorix® or MMR-II® ensures full, long-term protection and compliance with international travel and workplace health standards.
Cold-Chain and Safety Assurance
All MMR vaccines are transported and stored within +2 °C to +8 °C under continuous temperature monitoring.
Vaccination is performed by licensed medical professionals, with proper documentation, informed consent, and post-injection observation as part of Affinity Vaccines’ Corporate Program Management Protocol.
Protect Your People. Protect Your Business. Strengthen Your Organization.
Outbreaks of measles, mumps, or rubella can disrupt workplaces and pose serious health risks, particularly to unvaccinated adults and pregnant women.
Affinity Vaccines delivers safe and efficient MMR immunization programs for employees and dependents — ensuring compliance, protection, and peace of mind.
📩 Request for a Corporate Vaccination Proposal
Email: vaccines@affinity.com.ph